You are here: Industry Insights > Retr

News List

RetroBrain Announces Strategic Cooperation with Schenker Technologies and a Grant for its Second Product Line “memoreHome” b3cnewswire
September 13, 2021
Hamburg based digital health growth company RetroBrain R&D GmbH (“RetroBrain”) announces initial strategic cooperation with Schenker Technologies, a leading provider of IT and gaming hardware...
Bio-Techne's RNAscope™ Technology Aids in the Retrospective Tissue Diagnosis of COVID-19 in cases with no previous testing for SARS-CoV-2 prnewswire
August 05, 2021
Bio-Techne Corporation (NASDAQ: TECH) today announced that scientists at the U.S. Centers for Disease Control and Prevention (CDC) recently highlighted the importance of fixed tissue analysis for retrospective diagnosis of SARS-CoV-2 infection
Charles River Acquires Retrogenix contractpharma
April 06, 2021
Charles River Laboratories has acquired early-stage contract research organization (CRO) Retrogenix, a provider of specialized bioanalytical services utilizing its proprietary cell microarray technology, for $48 million.
Retrophin Completes Acquisition of Orphan Technologies americanpharmaceuticalreview
November 25, 2020
Retrophin announced the completion of its previously announced acquisition of Orphan Technologies Limited, a privately held, clinical-stage biopharmaceutical company focused on the development of product candidate OT-58 for the treatment of classical ...
Mallinckrodt launches retrospective study for inhaled therapy in COVID-19 pharmatimes
November 12, 2020
Mallinckrodt has launched a retrospective chart review study which will collect real-world data on the use of INOmax (nitric oxide) gas for inhalation therapy in patients with respiratory complications associated with COVID-19.
Retrophin to Acquire Orphan Technologies americanpharmaceuticalreview
October 26, 2020
Retrophin has entered into a definitive agreement to acquire Orphan Technologies, a privately held, clinical-stage biopharmaceutical company focused on the development of product candidate OT-58 for the treatment of classical homocystinuria (HCU).
CaDi introduces Lycofertilic™ - high potency, targeted supplements with algae DHA Omega-3 to provide anti-ageing support for the ovarian reserve and to prepare for egg retrieval and IVF prnasia
October 23, 2020
Cambridge Diagnostic Imaging (CaDi) is launching a new generation of targeted daily supplements, LycofertilicTM for fertility support and LycofertilicTM Prime to prepare for egg retrieval and IVF.
Jacobs to Retrofit AstraZeneca’s Mfg. Facility for COVID-19 Vax contractpharma
June 16, 2020
Will upgrade an existing idle Fill Line in West Chester, OH to support formulation, vial filling, visual inspection and packaging of the COVID-19 vaccine.
The Lancet retracts study linking hydroxychloroquine with deaths pharmatimes
June 08, 2020
The Lancet has issued a statement that a study which indicated that hydroxychloroquine was linked with higher rates of death in COVID-19 patients has been retracted, after three of its authors said they were unable to 'vouch for the veracity of the primar
Gilead Requests Retraction of Orphan Designation for Remdesivir contractpharma
March 26, 2020
Seeks to waive all benefits amid growing concerns the specialty status could impact pricing and availability of competitor products.